FDA Approves Enhertu for HER2-Positive Solid Tumors

Personal Loss Plays ‘Profound Role’ in Shaping Doctor’s Career Path

Nelli Bejanyan, MD, talks about why she became a physician, what motivates her and the important lessons she’s learned from patients

Scientist Sees Metabolism Research Driving Potential for New Cancer Therapies

Gina DeNicola, PhD, discusses learning the ‘language of biology,’ moving cells out of the dish and the promise of patient data

Retired NY Police Officer Runs Boston Marathon 6 Months After Lung Cancer Surgery

Vinny O’Shaughnessy started training again soon after part of right lung removed

From Employee to Volunteer: Lee Lockrem's Inspiring Journey at Moffitt

Meet Moffitt’s Volunteer of the Year

Olivia Munn in Medically Induced Menopause To Reduce Breast Cancer Recurrence

Moffitt expert explains the phenomenon and how it lower the chance of cancer returning

Bringing Cancer Education to the Caribbean

Moffitt experts visit Puerto Rico to educate on cancer prevention, early detection and treatment options.

Past Gift Sparks Future Breakthroughs and FDA Approval

Donation made 17 years ago changed the future of cancer research at Moffitt

FDA Approves Enhertu for HER2-Positive Solid Tumors

The announcement makes it the first HER2-directed therapy for multiple cancer types

Remembering Longtime Moffitt Champion Bob Graham

Former Florida governor and U.S. senator dies at 87